光明中医2026，Vol.41Issue(4)：53-57,5.DOI:10.70976/j.issn.1003-8914.2026.04.013
同仁大活络丸干预风寒湿痹阻型痹证临床研究
Clinical Study on Tongren Dahuoluo Pills in the Treatment of Bi Syndrome Due to Wind-Cold-Dampness Obstruction Type
郝婷婷 1庄扬名 1孔繁飞 1何川2
作者信息
- 1. 北京同仁堂中医医院内科,北京 100051
- 2. 北京同仁堂股份有限公司经营分公司,北京 100171
- 折叠
摘要
Abstract
Objective To investigate the comprehensive efficacy and safety of Tongren Dahuoluo pills in the treatment of bi syndrome due to wind-cold-dampness obstruction type.Methods A self-controlled before-and-after design was adopted.A total of 150 patients with bi syndrome due to wind-cold-dampness obstruction type who were treated at Beijing Tongrentang Hospital of Traditional Chinese Medicine from April 2024 to December 2024 were enrolled,and all received oral Tongren Dahuoluo pills for 30 days.Before and after treatment,symptoms and signs were evaluated using the traditional Chinese medicine(TCM)syndrome scale,visual analogue scale(VAS),Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC),and neck disability index(NDI).Safety indicators and adverse reactions were monitored.Results A total of 136 cases were included in the statistical analysis(14 cases dropped out).Compared with before treatment,TCM syndromes including joint pain,limited motion,swelling,and pain severity were significantly improved(P<0.001).Knee joint function and neck-shoulder mobility were also significantly enhanced(P<0.001).The total effective rate was 95.6%.No serious adverse reactions occurred during treatment,and no obvious abnormalities were found in safety indicators.Conclusion Tongren Dahuoluo pills had favorable efficacy in the treatment of bi syndrome due to wind-cold-dampness obstruction,could effectively improve patients'symptoms,and showed good safety.关键词
痹证/风寒湿痹证/同仁大活络丸Key words
bi syndrome/wind-cold-dampness bi syndrome/Tongren Dahuoluo pills分类
医药卫生引用本文复制引用
郝婷婷,庄扬名,孔繁飞,何川..同仁大活络丸干预风寒湿痹阻型痹证临床研究[J].光明中医,2026,41(4):53-57,5.
